Shaoxue Ding, Tian Zhang, Yingying Lei, Chunyan Liu, Zhaoyun Liu, Rong Fu
{"title":"TIM3+ NK 和 TIM3- NK 细胞在重型再生障碍性贫血免疫发病机制中的作用。","authors":"Shaoxue Ding, Tian Zhang, Yingying Lei, Chunyan Liu, Zhaoyun Liu, Rong Fu","doi":"10.2478/jtim-2023-0104","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Natural killer (NK) cells play important immunoregulatory roles in the immune pathogenesis of severe aplastic anemia (SAA). Our previous research showed that SAA caused a decrease in T cell immunoglobulin mucin-3 (TIM3) expression on NK cells. Here we investigated the expression of surface receptors, and the cytotoxicity of peripheral TIM3<sup>+</sup> NK and TIM3<sup>-</sup> NK cells in patients with SAA.</p><p><strong>Methods: </strong>The expressions of surface receptors and cytoplasmic protein of TIM3<sup>+</sup> NK and TIM3<sup>-</sup> NK cells from peripheral blood were detected by FCM. The functions of mDCs, and apoptosis rate of K562 cells after co-culture with TIM3<sup>+</sup> NK and TIM3<sup>-</sup> NK cells were maesured by FCM. Westren-blot was used to detect the changes of TIM3<sup>+</sup> NK and TIM3<sup>-</sup> NK signaling pathway proteins (AKT, P-AKT) and compare the functional activity of the two groups.</p><p><strong>Results: </strong>Activating receptors NKG2D and Granzyme B were higher, while inhibiting receptors NKG2A, CD158a and CD158b were lower on TIM3<sup>-</sup> NK cells compared with TIM3<sup>+</sup> NK cells in patients with SAA. In SAA, the expression of CD80 and CD86 on mDCs (Myeloid dendritic cells) was significantly decreased after incubation with TIM3<sup>-</sup> NK cells. The apoptosis rate (AR) of K562 cells was significantly increased after being incubated with TIM3<sup>-</sup> NK cells in SAA. The level of signal pathway protein AKT of TIM3<sup>-</sup> NK cells in SAA was similar to that of TIM3<sup>+</sup> NK cells, and the levels of P-AKT and P-AKT/AKT ratio of TIM3<sup>-</sup> NK cells were significantly higher than those of TIM3<sup>+</sup> NK cells.</p><p><strong>Conclusions: </strong>Therefore, TIM3 exerts its inhibitory effect on NK cells and participates in the immune pathogenesis of SAA. Low expression of TIM3 contributes to the enhancement of NK cell activity which in turn inhibits the immune activation state of SAA and improves the disease state. Our research may aid the development of new therapeutic strategies based on TIM3-NK cells infusion for the treatment of SAA.</p>","PeriodicalId":51339,"journal":{"name":"Journal of Translational Internal Medicine","volume":"12 1","pages":"96-105"},"PeriodicalIF":4.7000,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10956726/pdf/","citationCount":"0","resultStr":"{\"title\":\"The role of TIM3<sup>+</sup> NK and TIM3<sup>-</sup> NK cells in the immune pathogenesis of severe aplastic anemia.\",\"authors\":\"Shaoxue Ding, Tian Zhang, Yingying Lei, Chunyan Liu, Zhaoyun Liu, Rong Fu\",\"doi\":\"10.2478/jtim-2023-0104\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Natural killer (NK) cells play important immunoregulatory roles in the immune pathogenesis of severe aplastic anemia (SAA). Our previous research showed that SAA caused a decrease in T cell immunoglobulin mucin-3 (TIM3) expression on NK cells. Here we investigated the expression of surface receptors, and the cytotoxicity of peripheral TIM3<sup>+</sup> NK and TIM3<sup>-</sup> NK cells in patients with SAA.</p><p><strong>Methods: </strong>The expressions of surface receptors and cytoplasmic protein of TIM3<sup>+</sup> NK and TIM3<sup>-</sup> NK cells from peripheral blood were detected by FCM. The functions of mDCs, and apoptosis rate of K562 cells after co-culture with TIM3<sup>+</sup> NK and TIM3<sup>-</sup> NK cells were maesured by FCM. Westren-blot was used to detect the changes of TIM3<sup>+</sup> NK and TIM3<sup>-</sup> NK signaling pathway proteins (AKT, P-AKT) and compare the functional activity of the two groups.</p><p><strong>Results: </strong>Activating receptors NKG2D and Granzyme B were higher, while inhibiting receptors NKG2A, CD158a and CD158b were lower on TIM3<sup>-</sup> NK cells compared with TIM3<sup>+</sup> NK cells in patients with SAA. In SAA, the expression of CD80 and CD86 on mDCs (Myeloid dendritic cells) was significantly decreased after incubation with TIM3<sup>-</sup> NK cells. The apoptosis rate (AR) of K562 cells was significantly increased after being incubated with TIM3<sup>-</sup> NK cells in SAA. The level of signal pathway protein AKT of TIM3<sup>-</sup> NK cells in SAA was similar to that of TIM3<sup>+</sup> NK cells, and the levels of P-AKT and P-AKT/AKT ratio of TIM3<sup>-</sup> NK cells were significantly higher than those of TIM3<sup>+</sup> NK cells.</p><p><strong>Conclusions: </strong>Therefore, TIM3 exerts its inhibitory effect on NK cells and participates in the immune pathogenesis of SAA. Low expression of TIM3 contributes to the enhancement of NK cell activity which in turn inhibits the immune activation state of SAA and improves the disease state. Our research may aid the development of new therapeutic strategies based on TIM3-NK cells infusion for the treatment of SAA.</p>\",\"PeriodicalId\":51339,\"journal\":{\"name\":\"Journal of Translational Internal Medicine\",\"volume\":\"12 1\",\"pages\":\"96-105\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2024-03-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10956726/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Translational Internal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2478/jtim-2023-0104\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Translational Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2478/jtim-2023-0104","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:自然杀伤(NK)细胞在重型再生障碍性贫血(SAA)的免疫发病机制中发挥着重要的免疫调节作用。我们之前的研究表明,SAA 会导致 NK 细胞上的 T 细胞免疫球蛋白粘蛋白-3(TIM3)表达减少。在此,我们研究了 SAA 患者外周 TIM3+ NK 细胞和 TIM3- NK 细胞表面受体的表达及细胞毒性:方法:用FCM检测外周血中TIM3+ NK和TIM3- NK细胞表面受体和胞浆蛋白的表达。用 FCM 检测 mDCs 的功能以及 K562 细胞与 TIM3+ NK 和 TIM3- NK 细胞共培养后的凋亡率。用 Westren-blot 检测 TIM3+ NK 和 TIM3- NK 信号通路蛋白(AKT、P-AKT)的变化,比较两组细胞的功能活性:结果:与TIM3+ NK细胞相比,SAA患者TIM3- NK细胞的激活受体NKG2D和颗粒酶B含量更高,而抑制受体NKG2A、CD158a和CD158b含量更低。在 SAA 患者中,与 TIM3- NK 细胞培养后,髓系树突状细胞(mDCs)上的 CD80 和 CD86 表达明显降低。在 SAA 中,与 TIM3- NK 细胞培养后,K562 细胞的凋亡率(AR)明显增加。SAA中TIM3- NK细胞的信号通路蛋白AKT水平与TIM3+ NK细胞相似,TIM3- NK细胞的P-AKT水平和P-AKT/AKT比值明显高于TIM3+ NK细胞:因此,TIM3对NK细胞具有抑制作用,参与了SAA的免疫发病机制。TIM3的低表达有助于增强NK细胞的活性,进而抑制SAA的免疫激活状态,改善疾病状态。我们的研究可能有助于开发基于 TIM3-NK 细胞输注治疗 SAA 的新疗法。
The role of TIM3+ NK and TIM3- NK cells in the immune pathogenesis of severe aplastic anemia.
Background: Natural killer (NK) cells play important immunoregulatory roles in the immune pathogenesis of severe aplastic anemia (SAA). Our previous research showed that SAA caused a decrease in T cell immunoglobulin mucin-3 (TIM3) expression on NK cells. Here we investigated the expression of surface receptors, and the cytotoxicity of peripheral TIM3+ NK and TIM3- NK cells in patients with SAA.
Methods: The expressions of surface receptors and cytoplasmic protein of TIM3+ NK and TIM3- NK cells from peripheral blood were detected by FCM. The functions of mDCs, and apoptosis rate of K562 cells after co-culture with TIM3+ NK and TIM3- NK cells were maesured by FCM. Westren-blot was used to detect the changes of TIM3+ NK and TIM3- NK signaling pathway proteins (AKT, P-AKT) and compare the functional activity of the two groups.
Results: Activating receptors NKG2D and Granzyme B were higher, while inhibiting receptors NKG2A, CD158a and CD158b were lower on TIM3- NK cells compared with TIM3+ NK cells in patients with SAA. In SAA, the expression of CD80 and CD86 on mDCs (Myeloid dendritic cells) was significantly decreased after incubation with TIM3- NK cells. The apoptosis rate (AR) of K562 cells was significantly increased after being incubated with TIM3- NK cells in SAA. The level of signal pathway protein AKT of TIM3- NK cells in SAA was similar to that of TIM3+ NK cells, and the levels of P-AKT and P-AKT/AKT ratio of TIM3- NK cells were significantly higher than those of TIM3+ NK cells.
Conclusions: Therefore, TIM3 exerts its inhibitory effect on NK cells and participates in the immune pathogenesis of SAA. Low expression of TIM3 contributes to the enhancement of NK cell activity which in turn inhibits the immune activation state of SAA and improves the disease state. Our research may aid the development of new therapeutic strategies based on TIM3-NK cells infusion for the treatment of SAA.